Liver-specific SLC13A3 modulation alleviates MASLD by regulating NAD+ metabolism

Puntos clave

• Alleviating MASLD is achievable through regulation of NAD+ metabolism, enhancing liver function.
• Key evidence indicated a significant decrease in MASLD symptoms correlating with SLC13A3 modulation.
• Analysis of liver tissue shows how specific modulation of SLC13A3 impacts NAD+ levels and metabolic activity.
• This approach highlights a promising pathway for treating metabolic disorders related to liver health.